Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paige H R Mallinger

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
NPJ Precision Oncology|July 9, 2025
RAS pathway targeted therapy in patients with DICER1-associated sarcomasLindy Zhang, Paige H R Mallinger, Serena Zhou, et al.
JCO Precision Oncology|April 23, 2025
Prognostic Significance of Germline <i>DICER1</i> Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell TumorAlexander T Nelson, Dave Watson, Kenneth S Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2024
Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis ComplexKris Ann P Schultz, Suzanne P MacFarland, Melissa R Perrino, et al.
Cancer|April 23, 2025
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 RegistriesAnne K Harris, Alexander T Nelson, Dave Watson, et al.
Gynecologic Oncology|April 24, 2024
Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor RegistriesAlexander T Nelson, Anne K Harris, Dave Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2024
DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance StrategiesKris Ann P Schultz, Alexander T Nelson, Paige H R Mallinger, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
NPJ Precision Oncology|July 9, 2025
RAS pathway targeted therapy in patients with DICER1-associated sarcomasLindy Zhang, Paige H R Mallinger, Serena Zhou, et al.
JCO Precision Oncology|April 23, 2025
Prognostic Significance of Germline <i>DICER1</i> Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell TumorAlexander T Nelson, Dave Watson, Kenneth S Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2024
Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis ComplexKris Ann P Schultz, Suzanne P MacFarland, Melissa R Perrino, et al.
Cancer|April 23, 2025
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 RegistriesAnne K Harris, Alexander T Nelson, Dave Watson, et al.
Gynecologic Oncology|April 24, 2024
Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor RegistriesAlexander T Nelson, Anne K Harris, Dave Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2024
DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance StrategiesKris Ann P Schultz, Alexander T Nelson, Paige H R Mallinger, et al.
Pageof 1